Key Financial’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.96K Hold
710
– – ﹤0.01% 882
2026
Q2
$10.3K Hold
710
– – ﹤0.01% 863
2026
Q1
$9.8K Hold
710
– – ﹤0.01% 885
2025
Q4
$10K Hold
710
– – ﹤0.01% 886
2025
Q3
$10.1K Hold
710
– – ﹤0.01% 878
2025
Q2
$10.7K Hold
710
– – ﹤0.01% 838
2025
Q1
$9.36K Hold
710
– – ﹤0.01% 832
2024
Q4
$11.2K Hold
710
– – ﹤0.01% 797
2024
Q3
$11.3K Hold
710
– – ﹤0.01% 763
2024
Q2
$10.8K Hold
710
– – ﹤0.01% 752
2024
Q1
$10.4K Hold
710
– – ﹤0.01% 741
2023
Q4
$9.9K Hold
710
– – ﹤0.01% 739
2023
Q3
$9.5K Hold
710
– – ﹤0.01% 725
2023
Q2
$8.96K Buy
+710
New +$8.29K ﹤0.01% 764

Other funds holding RDY

Key Financial's RDY Position: Q3 2026 in Review

Key Financial held its Dr. Reddy's Laboratories (RDY) position steady in Q3 2026 at 710 shares worth $8.96K. The position accounts for ﹤0.01% of the portfolio, ranked #882.

Key Financial first reported a position in RDY in Q2 2023 and has held it in 14 quarters since. The position peaked at $11.3K in Q3 2024. 184 funds tracked by Wall St. Rank hold RDY as of Q3 2026.

  • Key Financial held 710 shares of Dr. Reddy's Laboratories worth $8.96K as of Q3 2026.
  • Key Financial left its Dr. Reddy's Laboratories share count unchanged in Q3 2026.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Key Financial's portfolio in Q3 2026, its #882 holding.
  • Key Financial first reported a position in Dr. Reddy's Laboratories in Q2 2023 and has held it in 14 quarters since.
  • Key Financial's Dr. Reddy's Laboratories position peaked at $11.3K in Q3 2024.
  • 184 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2026.

Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.